HNRNPA1 and cancer: Overall, our work contributes to an emerging field of research focused on protein ArgMe as biomarkers of disease and treatment, for example, recent investigations have proposed a novel cancer biomarker based on ArgMe of an RNA binding protein, hnRNP-A1, in blood mononuclear cells (Noto et al. 2020).